DOI QR코드

DOI QR Code

Acute Liver Failure Secondary to Hepatic Infiltration of Malignant Melanoma

  • Yujin Lee (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Jaekwang Lee (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Hyunsoo Kim (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Changkeun Park (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Jaekwon Jung (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Daejin Kim (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Yun Jin Chung (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Hanjun Ryu (Department of Internal Medicine, Daegu Fatima Hospital)
  • Received : 2020.10.16
  • Accepted : 2021.01.22
  • Published : 2022.03.30

Abstract

Acute liver failure due to malignant melanoma is uncommon. We presents a case of acute liver failure secondary to hepatic infiltration of a malignant melanoma. An 86-year-old man was admitted with elevated liver enzymes and an increased lactate dehydrogenase level. His condition progressed to acute liver failure, but the etiology of liver failure was unclear. Esophagogastroduodenoscopy was performed to evaluate dyspepsia, which showed signs indicative of malignant melanoma. Based on the endoscopy findings and elevated liver enzyme levels, liver biopsy was performed to confirm the presence of malignant melanoma. Hepatic infiltration of malignant melanoma was observed histologically. However, massive and diffuse liver metastasis is very rare and difficult to identify on imaging studies. If the etiology of liver failure is unclear, diffuse metastatic melanoma infiltration should be considered as differential diagnosis. Early liver biopsy can help to clarify the diagnosis.

Keywords

References

  1. Curti BD, Leachman S, Urba WJ. Cancer of the Skin. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, eds. Harrison's principles of internal medicine 20th ed. New York (NY): McGraw-Hill Education; 2018. p. 522-530. 
  2. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-1678. 
  3. Dasgupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 1963;117:341-345. 
  4. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950-955. 
  5. Te HS, Schiano TD, Kahaleh M, et al. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol 1999;94:262-266. 
  6. Montero JL, Muntane J, de las Heras S, Ortega R, Fraga E, De la Mata M. Acute liver failure caused by diffuse hepatic melanoma infiltration. J Hepatol 2002;37:540-541. 
  7. Schlevogt B, Rehkamper J, Hild B, Schmidt HH. Hepatobiliary and pancreatic: fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma. J Gastroenterol Hepatol 2017;32:1795.